Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Pharmacokinetics, biodistribution, and activity of Amphotericin B-loaded nanocochleates on the Leishmania donovani murine visceral leishmaniasis model

Antonio Lipa Castro, Sébastien Pomel, Catherine Cailleau, Natalie Fournier, Indira Dennemont, Philippe M. Loiseau and Gillian Barratt
International Journal of Pharmaceutics 624 121985 (2022)
https://doi.org/10.1016/j.ijpharm.2022.121985

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates

Philippe M. Loiseau, Kaluvu Balaraman, Gillian Barratt, Sébastien Pomel, Rémy Durand, Frédéric Frézard and Bruno Figadère
Molecules 27 (7) 2313 (2022)
https://doi.org/10.3390/molecules27072313

Comparative study of the chemical properties and composition of the Mentha Pulegium L. of Algerian origin and that of Tunisian origin

Barhoumi Mondher
International Journal of Agricultural Science and Food Technology 6 (1) 030 (2020)
https://doi.org/10.17352/2455-815X.000051

Recent synthetic efforts in the preparation of 2-(3,4)-alkenyl (aryl) quinoline molecules towards anti-kinetoplastid agents

Dayana Orozco, Vladimir V. Kouznetsov, Armando Bermúdez, et al.
RSC Advances 10 (9) 4876 (2020)
https://doi.org/10.1039/C9RA09905K

Insights into the current status of privileged N-heterocycles as antileishmanial agents

Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, et al.
Molecular Diversity 24 (2) 525 (2020)
https://doi.org/10.1007/s11030-019-09953-4

GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis

Sébastien Pomel, Wei Mao, Tâp Ha-Duong, Christian Cavé and Philippe M. Loiseau
Frontiers in Cellular and Infection Microbiology 9 (2019)
https://doi.org/10.3389/fcimb.2019.00186

Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases

Vladimir V. Kouznetsov, Carlos M. Meléndez Gómez, José Luis Valencia Peña and Leonor Y. Vargas-Méndez
Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases 87 (2019)
https://doi.org/10.1016/B978-0-12-815723-7.00004-3

New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani

Vasanthan Ravichandran, Nalia Mekarnia, Sébastien Pomel, et al.
Regenerative Engineering and Translational Medicine 4 (1) 11 (2018)
https://doi.org/10.1007/s40883-018-0045-3

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, et al.
F1000Research 4 34 (2015)
https://doi.org/10.12688/f1000research.6110.1

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, et al.
F1000Research 4 34 (2015)
https://doi.org/10.12688/f1000research.6110.2

In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route

Kaluvu Balaraman, Nashira Campos Vieira, Fathi Moussa, Joël Vacus, Sandrine Cojean, Sébastien Pomel, Christian Bories, Bruno Figadère, Ventikasamy Kesavan and Philippe M. Loiseau
Biomedicine & Pharmacotherapy 76 127 (2015)
https://doi.org/10.1016/j.biopha.2015.10.028